Pharmafile Logo

transcreation

- PMLiVE

Eli Lilly’s Alzheimer’s drug shown to significantly slow disease progression in phase 3 trial

Donanemab slowed the progression of early Alzheimer’s disease by 35% compared to placebo

- PMLiVE

AI model shows promise in detecting lung cancer earlier

Lung cancer accounts for more than 20% of cancer deaths in the UK

- PMLiVE

Improving outcomes for prostate cancer patients

Prostate cancer is the most common cancer in men across the United Kingdom, with approximately one in eight men being diagnosed with prostate cancer at some point in their life

Closing the Gaps in Telehealth

Anthony Capone, President of DocGo, shares how his company uses last-mile mobile health services and integrated medical transportation solutions to make healthcare more accessible for everyone, including underserved populations.To find...

Impetus Digital

- PMLiVE

Medscape Present Outcomes of Neurology Education at AAN 2023

Medscape had education outcomes on the brain for this year’s AAN conference in Boston.During the conference, Medscape presented 5 scientific posters describing the impact of continuing medical education in migraine,...

Medscape Education

ChatGPT AI copywriter: Looming threat or opportunity to evolve?

Even as someone who makes a living working in healthcare communications, I can still spend many hours copywriting without much progress – it is the nature of the beast [come...

Page & Page Health

- PMLiVE

Janssen signs $245m deal with Cellular Biomedicine for pair of CAR T-cell therapies

The candidates have shown the potential to treat forms of non-Hodgkin’s lymphoma

- PMLiVE

FDA issues new draft guidance on decentralised clinical trials

The document includes recommendations on trial design and the use of digital health technologies

- PMLiVE

Confidently omnichannel: the critical role of customer engagement

Why a successful leap from multichannel to omnichannel is within your grasp

AMICULUM® collaborates with the University of Dundee to develop a new Master’s course in Science and Health Communication

AMICULUM Limited is proud to announce its collaboration with the University of Dundee in developing a Master’s course in Science and Health Communication. The Master’s course was an idea conceived...

Amiculum

- PMLiVE

Almirall and Eli Lilly’s lebrikizumab shows continued improvement in atopic dermatitis

The common inflammatory skin disease affects over 4% of adults in the EU

- PMLiVE

Sanofi signs agreement worth up to $750m for Maze’s Pompe disease drug

The candidate has recently cleared its first phase 1 clinical trial

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links